Guggenheim Capital LLC Tekla Life Sciences Investors Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q1 2024

A detailed history of Guggenheim Capital LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Guggenheim Capital LLC holds 25,623 shares of HQL stock, worth $341,298. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,623
Previous 29,187 12.21%
Holding current value
$341,298
Previous $392,000 10.97%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$13.38 - $14.33 $47,686 - $51,072
-3,564 Reduced 12.21%
25,623 $349,000
Q4 2023

Feb 14, 2024
BUY
$11.35 - $13.6 $12,246 - $14,674
1,079 Added 3.84%
29,187 $392,000
Q3 2023

Nov 14, 2023
BUY
$12.38 - $13.69 $1,386 - $1,533
112 Added 0.4%
28,108 $350,000
Q2 2023

Aug 11, 2023
BUY
$13.13 - $14.17 $39,665 - $42,807
3,021 Added 12.1%
27,996 $379,000
Q1 2023

May 10, 2023
BUY
$13.37 - $14.94 $190,402 - $212,760
14,241 Added 132.67%
24,975 $347,000
Q4 2022

Feb 14, 2023
BUY
$13.55 - $15.23 $145,445 - $163,478
10,734 New
10,734 $152,000
Q1 2022

May 16, 2022
SELL
$15.35 - $19.29 $165,657 - $208,177
-10,792 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$18.5 - $21.59 $217,541 - $253,876
-11,759 Reduced 52.14%
10,792 $208,000
Q3 2021

Nov 15, 2021
BUY
$20.27 - $22.67 $891 - $997
44 Added 0.2%
22,551 $469,000
Q2 2021

Aug 13, 2021
SELL
$19.14 - $21.44 $33,686 - $37,734
-1,760 Reduced 7.25%
22,507 $483,000
Q1 2021

May 13, 2021
SELL
$19.31 - $22.07 $20,816 - $23,791
-1,078 Reduced 4.25%
24,267 $479,000
Q4 2020

Feb 16, 2021
SELL
$16.8 - $20.21 $1,932 - $2,324
-115 Reduced 0.45%
25,345 $500,000
Q3 2020

Nov 13, 2020
BUY
$16.71 - $19.06 $57,365 - $65,432
3,433 Added 15.59%
25,460 $447,000
Q2 2020

Aug 14, 2020
SELL
$14.22 - $18.38 $123,458 - $159,575
-8,682 Reduced 28.27%
22,027 $396,000
Q1 2020

Jun 02, 2020
BUY
$12.22 - $17.99 $81,311 - $119,705
6,654 Added 27.66%
30,709 $460,000
Q4 2019

Feb 14, 2020
BUY
$14.63 - $17.84 $107,823 - $131,480
7,370 Added 44.17%
24,055 $419,000
Q3 2019

Nov 14, 2019
SELL
$15.09 - $17.09 $16,810 - $19,038
-1,114 Reduced 6.26%
16,685 $252,000
Q2 2019

Aug 14, 2019
SELL
$15.54 - $17.47 $1,351 - $1,519
-87 Reduced 0.49%
17,799 $300,000
Q1 2019

May 15, 2019
SELL
$15.5 - $17.9 $7,967 - $9,200
-514 Reduced 2.79%
17,886 $306,000
Q4 2018

Feb 14, 2019
BUY
$13.99 - $20.35 $58,128 - $84,554
4,155 Added 29.17%
18,400 $278,000
Q3 2018

Nov 14, 2018
BUY
$18.89 - $20.49 $269,088 - $291,880
14,245 New
14,245 $291,000

Others Institutions Holding HQL

# of Institutions
80
Shares Held
8.52M
Call Options Held
0
Put Options Held
0
View Full List

About TEKLA LIFE SCIENCES INVESTORS

HQL Quotes by TradingView
  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email